ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.05M
Enterprise Value 37.89M
Trailing P/E 1.89
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.58
Price/Book (mrq)0.93
Enterprise Value/Revenue 31.13
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.16
52-Week Change 3-2.12%
S&P500 52-Week Change 32.12%
52 Week High 30.2900
52 Week Low 30.1900
50-Day Moving Average 30.2469
200-Day Moving Average 30.2409

Share Statistics

Avg Vol (3 month) 320.54k
Avg Vol (10 day) 311.07k
Shares Outstanding 544.21M
Float 28.09M
% Held by Insiders 113.11%
% Held by Institutions 124.43%
Shares Short (Apr 29, 2016) 4157.47k
Short Ratio (Apr 29, 2016) 41.03
Short % of Float (Apr 29, 2016) 40.41%
Short % of Shares Outstanding (Apr 29, 2016) 40.36%
Shares Short (prior month Mar 31, 2016) 4507.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 21, 2019
Ex-Dividend Date 4Feb 20, 2019
Last Split Factor (new per old) 21/1
Last Split Date 3Sep 29, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 85.31%
Operating Margin (ttm)85.41%

Management Effectiveness

Return on Assets (ttm)34.89%
Return on Equity (ttm)58.02%

Income Statement

Revenue (ttm)7M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)239.30%
Gross Profit (ttm)6.92M
EBITDA N/A
Net Income Avi to Common (ttm)5.97M
Diluted EPS (ttm)0.1320
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.37M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)25.13
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-946k
Levered Free Cash Flow (ttm)-4.15M